Syndax Pharmaceuticals stock tumbles on failed IPF trial By Investing.com - Investing.com Nigeria
Source: Investing.com Nigeria ·
Syndax Pharmaceuticals stock tumbles on failed IPF trial By Investing.com Investing.com Nigeria
BestAIBroker analysis
- Finance-aware sentiment: negative (-0.70 on a -1 to +1 scale).
- Event classification: OTHER.
- Market importance score: 33/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: SNDX.